Mortality in the US Populations With Monoclonal Gammopathy of Undetermined Significance.

Ji, Mengmeng; Huber, John H; Schoen, Martin W; Sanfilippo, Kristen M; Colditz, Graham A; Wang, Shi-Yi; Chang, Su-Hsin

Ji, Mengmeng; Huber, John H; Schoen, Martin W; Sanfilippo, Kristen M; Colditz, Graham A; Wang, Shi-Yi; Chang, Su-Hsin.

Affiliation

Ji M; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, Missouri.
Huber JH; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, Missouri.
Schoen MW; Department of Medicine, Saint Louis University School of Medicine, St Louis, Missouri.
Sanfilippo KM; Medical Service, St Louis Veterans Affairs Medical Center, St Louis, Missouri.
Colditz GA; Medical Service, St Louis Veterans Affairs Medical Center, St Louis, Missouri.
Wang SY; Hematology Division, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.
Chang SH; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, Missouri.

JAMA Oncol ; 9(9): 1293-1295, 2023 09 01.

Article in En | MEDLINE | ID: mdl-37498610

This cohort study analyzes a nationally representative sample with a screening test for monoclonal gammopathy of undetermined significance (MGUS) to evaluate overall survival of populations with MGUS compared with those without MGUS among the general population in the US.

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Monoclonal Gammopathy of Undetermined Significance / Multiple Myeloma Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: JAMA Oncol Year: 2023 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google